# Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid Disorders

> **NCT00132418** · PHASE4 · COMPLETED · sponsor: **Amgen** · enrollment: 564 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Enbrel
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00132418
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-04
- **Primary completion:** 2004-02
- **Final completion:** 2004-02
- **Target enrollment:** 564 (ACTUAL)
- **Last updated:** 2011-01-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00132418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00132418, "Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid Disorders". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00132418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*